Perspective Therapeutics (CATX) Acquisitions (2023)

Perspective Therapeutics' (CATX) quarterly Acquisitions came in at $2.7 million in Q1 2023.

Perspective Therapeutics (CATX) Acquisitions (2023) Analysis & Trends

Perspective Therapeutics has disclosed Acquisitions across 1 years of filings, most recently posting $2.7 million for Q1 2023.

Acquisitions for Q1 2023 came in at $2.7 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $2.7 million (changed N/A YoY), and the FY2023 annual result was $2.7 million, changed N/A from the prior year.
Acquisitions came in at $2.7 million for Q1 2023 at Perspective Therapeutics.
In the past five years, Acquisitions ranged from a high of $2.7 million in Q1 2023 to a low of $2.7 million in Q1 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	22.00 Mn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	523.00 Mn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-268.10 Mn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	2.30 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	-
10	Perspective Therapeutics	308.74 Mn	308.74 Mn	-	-

Historic Data

Download Data

Date	Value
Mar 31, 2023	2.70 Mn